South Dakota House Bill 1169
Session 2026
Classify medetomidine as a Schedule III controlled substance and establish permissible uses.
Became Law
Signed by Governor on Mar 9, 2026
First Action
Jan 28, 2026
Latest Action
Mar 9, 2026
Origin Chamber
House
Type
Bill
Bill Number
1169
State
South Dakota
Session
2026
checkPassed on February 10, 2026
Motion Text
Do Pass
House Roll Call Votes
Excused
Yes
Yes
Excused
Yes
Yes
Summary
Unavailable
Sort by most recent
03/09/2026
Office of the Governor
Signed by the Governor on 2026-03-09 H.J. 534
03/04/2026
Senate
Delivered to the Governor on 2026-03-04 H.J. 497
03/03/2026
Senate
Signed by the President S.J. 448
03/02/2026
Senate
Signed by the Speaker H.J. 477
02/26/2026
Senate
Senate Do Pass , Passed, YEAS 32, NAYS 0 S.J. 412
02/25/2026
Senate
Certified uncontested, placed on consent , Passed, S.J. 21
02/25/2026
Senate
Health and Human Services Do Pass , Passed, YEAS 7, NAYS 0 S.J. 21
02/25/2026
Senate
Scheduled for hearing S.J. 1
02/12/2026
Senate
First read in Senate and referred to Senate Health and Human Services S.J. 260
02/11/2026
House
House of Representatives Do Pass , Passed, YEAS 63, NAYS 3 H.J. 295
02/10/2026
House
Certified uncontested, placed on consent , Passed,
02/10/2026
House
Health and Human Services Do Pass , Passed, YEAS 11, NAYS 0
02/10/2026
House
Scheduled for hearing
01/28/2026
House
First read in House and referred to House Health and Human Services H.J. 163
Sources
Open States
Record Created
Jan 28, 2026 4:29:20 AM
Record Updated
Mar 10, 2026 1:08:51 AM